News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 145–180
- Matches
- 12816
- Sources here
- 20
- Companies here
- 38
Active search
12816 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Why Did ICL Group (ICL) Move Today?
ICL Group (NYSE:ICL) recently reported strong Q2 2026 sales and net income, along with board approval for a new operating model. This news has led to a 9.90% share price increase over 30 days, despite longer-term declines. The company's valuation, at a P/E of …
InterContinental Hotels Group PLC Announces Transaction in Own Shares - August 17
Purchase of own shares LONDON, UK / ACCESS Newswire / August 17, 2026 / The Company announces that on 14 August 2026 it purchased the following number of its ordinary shares of 20340/399pence each through Goldman Sachs International ("GSI") on the London Stock Exchange …
Sharemaestro market context Trend signal active 52 weeks +31.7% · Next-week setup positive 55.1%FLSmidth: Transactions under share buy-back programme
FLSmidth A/S COMPANY ANNOUNCEMENT NO. 39-2026 FLSmidth & Co. A/S 17 August 2026 Copenhagen, Denmark On 18 May 2026, FLSmidth & Co. A/S ("FLSmidth") initiated a share buy-back programme of up to DKK 1.0 billion (ref. Company Announcement no. 26-2025). Under the share buy-back …
Sharemaestro market context Price above Trend Line 52 weeks +22.8%Q3 EPS Estimate for Inovio Pharmaceuticals Raised by Analyst
HC Wainwright has increased its Q3 2026 EPS estimate for Inovio Pharmaceuticals (NASDAQ:INO) to a loss of $0.20 per share, up from a previous estimate of $0.24, while maintaining a "Neutral" rating. Analyst sentiment for Inovio is generally positive, with a consensus "Moderate Buy" …
Rocket Pharmaceuticals (NASDAQ:RCKT) Upgraded by Wall Street Zen to "Hold" Rating
Wall Street Zen has upgraded Rocket Pharmaceuticals (NASDAQ:RCKT) from a "sell" to a "hold" rating, aligning with the broader analyst consensus and an average target price of $8.57. The company's shares opened at $3.47 and have seen significant insider selling totaling $327,220 over the …
Citius Pharmaceuticals GAAP EPS of -$0.34 misses by $0.09, revenue of $1.5M misses by $8.27M
* Citius Pharmaceuticals press release [https://seekingalpha.com/pr/20620155-citius-pharmaceuticals-inc-reports-fiscal-third-quarter-2026-financial-results-and-provides] (CTXR [https://seekingalpha.com/symbol/CTXR]): Q3 GAAP EPS of -$0.34 misses by $0.09. * Revenue of $1.5M misses by $8.27M. * Cash and cash equivalents of $17.0 million as of June 30, 2026. MORE ON CITIUS PHARMACEUTICALS * Seeking Alpha’s Quant …
IHG and Harilela Group announce The Hari's three hotels will join luxury collection brand Vignette Collection
IHG Hotels & Resorts has signed a deal with Harilela Group to bring three "The Hari" hotels into its Vignette Collection luxury brand. The Hari London and The Hari Hong Kong will join this year, while the Holiday Inn Singapore Orchard City Centre will …
RKLB Stock Rises Overnight: Rocket Lab’s First 8 Satellites From $143M Globalstar Deal Reach Orbit
Rocket Lab's stock (RKLB) rose overnight after the company confirmed that the first eight satellites built under its $143 million contract with MDA Space successfully reached orbit. These satellites, part of a 17-platform deal, will support Globalstar’s direct-to-device communications and IoT services. The successful …